Oral arsenic treatment of leukemia and the risk of porphyria

Leuk Res. 2009 Apr;33(4):598-600. doi: 10.1016/j.leukres.2008.08.016. Epub 2008 Oct 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Arsenic Trioxide
  • Arsenicals / administration & dosage
  • Arsenicals / adverse effects*
  • Female
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Oxides / administration & dosage
  • Oxides / adverse effects*
  • Porphyrias / chemically induced*
  • Porphyrins / metabolism

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Porphyrins
  • Arsenic Trioxide